Emerging issues in stimulating apheresis platelet donors with platelet growth factors, the relative costs of apheresis and random donor platelet concentrates, optimal platelet transfusion dose, and leucoreduction of platelet products have caused renewed debate regarding apheresis products vs. random
Platelet counts before and after apheresis
β Scribed by L.C. Lasky; A.T. Lin; J.J. McCullough
- Book ID
- 114437636
- Publisher
- Elsevier Science
- Year
- 1981
- Tongue
- English
- Weight
- 197 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0372-1248
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To the Editor: We read with interest the article by Chaudhary et al. [1] evaluating the need for quality systems and standard operating procedures (SOP) in automated plateletpheresis for a developing country like India. We would like to suggest certain modifications in the flowchart proposed by th
## Abstract Kidney transplantation is considered the treatment of choice for most individuals with endβstage kidney disease, as well as the most costβeffective renal replacement therapy for the health care system that serves them. Immunologic sensitization, defined by the presence of antibodies dir